As of the most recent data, CRBP shows a P/E ratio of -1.25. That is below the Healthcare sector average of 24.78. Scroll down for historical charts and peer comparison views.

The Healthcare sector average P/E ratio is about 24.78. Corbus Pharmaceuticals Holdings is at -1.25, which is lower that average. That is roughly 105.0% below the sector mean. Use the comparison chart on this page to see how CRBP stacks up against individual peers as well.

Investors watch CRBP's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Corbus Pharmaceuticals Holdings's latest reading is -1.25. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this p/e ratio page, Stockcircle has Corbus Pharmaceuticals Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently -1.25) with ownership activity and broader fundamentals.

The Healthcare average P/E ratio is about 24.78, while CRBP is at -1.25. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.